期刊文献+

缓释化疗粒子与三维适形放疗治疗晚期直肠癌的疗效比较 被引量:1

Comparison of the efficacy of the slow-released chemotherapy particles and three-dimensional conformal radiotherapy in advanced rectum carcinoma
下载PDF
导出
摘要 目的比较5-FU化疗粒子与三维适行放疗治疗晚期直肠癌的疗效。方法将84例晚期直肠癌患者随机等分为两组,A组行5-FU化疗粒子植入术;B组行三维适形放疗,分别观察1年生存率、并发症发生率及有效率。结果 (1)两组1年生存率分别为57.16%、45.83%;A组生存率高于B组,差异有统计学意义(χ2=7.29;P<0.05);(2)两组并发症发生率分别为14.29%、28.57%,A组并发症发生率低于B组,差异有统计学意义(χ2=6.81;P<0.05);(3)两组治疗后有效率分别为88.09%、76.19%,A组有效率高于B组,差异有统计学意义(χ2=7.42;P<0.05)。结论 5-FU化疗粒子植入术治疗晚期直肠癌疗效较好。 Objective To compare the efficacy of slow-released chemotherapy particle implantation and three-dimensional conformal radiotherapy in the treatment of advanced rectum carcinoma. Methods 84 cases with advanced rectum carcinoma were randomly divided into two groups,group A were underwent slow-released chemotherapy particle implantation;group B were done by three-dimensional conformal radiotherapy,observing 1-year survival rate,complication and efficient rate. Results(1)The 1 year survival rates were 57.16% and 45.83%;the survival rate of group A was higher than group B,the difference had statistical significance(χ2=7.29;P0.05);(2)The complication rate were 14.29 % and 28.57%,group A was lower than the other,the difference had statistical significance(χ2=6.81;P0.05);③The effective rate were 88.09% and 76.19%,group A was higher than group B,the difference had statistical significance(χ2=7.42;P0.05). Conclusion Slow-released chemotherapy particle implantation is a useful therapy in the treatment of advanced rectum carcinoma.
机构地区 解放军第
出处 《临床军医杂志》 CAS 2011年第5期902-904,共3页 Clinical Journal of Medical Officers
关键词 直肠肿瘤 直肠癌 5-FU化疗粒子 三维适形放疗 rectal neoplasm rectum carcinoma slow-released chemotherapy particle three-dimensional conformal radiotherapy
  • 相关文献

参考文献10

  • 1McLeod HL, Sargent DJ, Marsh S,et al. Pharmacogenetlc predictors of adverse events and response to chemotherapy in metastatic rectum cancer: resuIts from north american gastrointestinal intergroup triaI N9741 [ J ]. J Clin Oncol, 2010,28( 20 ) : 3227-33.
  • 2Nishino M, Jackman DM, Hatabu H, et al. New response evaluation criteria in soIid tumors (recist) guidelines for advanced non-small cell Iung cancer: comparison with original recist and impact on assessment of tumor response to targeted therapy[ J]. AJR Am J Roentgeno1,2010,195 ( 3 ) : W221 -228.
  • 3Halle M, Schoenberg MH. Physical activity in the prevention and treatment of rectum carcinoma[ J 1. Dt.~h Ar'ztebl Int, 2009,106 (44) :722 -727.
  • 4Shimizu H, Kochi M, Kaiga T, et al. A case of spontaneous regression of advanced colon cancer[ J~. Anticancer Res,2010,30 (6) :2351 -2353.
  • 5刘弋,万圣云,郭爱军,王光升,王瑞祥.术前植入5-Fu缓释剂对大肠癌的治疗[J].安徽医科大学学报,2006,41(3):302-304. 被引量:3
  • 6Jhaveri PM, Teh BS, Paulino AC, et al. Helical tomotherapy significantly reduces dose to normal tissues when compared to 3DCRT for locally advanced rectal cancer[ J ]. Technol Cancer Res Treat,2009,8 (5) :379 -385.
  • 7Fummoto K, Kojima H, Takaya H,et al. A case of advanced ascending colon cancer, curatively resected after complete responsein left supraclavicular and paraaortic lymph nodes and liver metastases to FOLFOX4 therapy[J] : Gan To Kagaku Ryoho,2010, 37(2) :323 -326.
  • 8殷保兵,马保金,陈进宏,王一飞,沈宁佳,蔡端.大肠癌术中腹腔植入氟尿嘧啶植入剂的临床观察[J].中国临床医学,2006,13(5):767-768. 被引量:20
  • 9Chan AK, Worts AO, Jenken DA. Preoperative capecitabine andPelvic radiation in locally advanced rectal cancer-is it equivalent to 5-Fu. infusion plus leucovorin and radiotherapy [ J ]. Int J Radiat Oneol Biol Phys,2010,76(5 ) : 1413-1419.
  • 10陈明星,龚惠芸,陈敏.内镜下局部注射HCPT和5-FU治疗晚期大肠癌的临床观察[J].中国内镜杂志,2002,8(10):87-88. 被引量:2

二级参考文献19

  • 1卿三华.影响结直肠癌预后的临床和病理危险因素[J].中华胃肠外科杂志,2004,7(6):434-435. 被引量:11
  • 2万德森,李国材,占友庆,陈敏山.应用氟尿嘧啶肠腔化疗辅助结、直肠癌根治术的远期效果[J].临床外科杂志,1994,2(2):71-73. 被引量:17
  • 3马列,王一春.氟尿嘧啶栓用于直肠癌术前辅助化疗的研究[J].中国药学杂志,1994,29(7):433-435. 被引量:5
  • 4李世拥,于波.结直肠癌局部复发的外科治疗[J].中华胃肠外科杂志,2006,9(3):199-200. 被引量:22
  • 5Nelson R L, Freels S. A systematic review of hepatic artery chemotherapy after hepatic resection of colorectal cancer metastatic to the liver[ J ]. Dis Colon Rectum,2004,47:739 - 45.
  • 6Dube S,Heyen F, Jenicek M. Adjuvant chemotherapy in colorectal carcinoma: result of a meta-analysis [ J ]. Dis colon Rectum,1997,40(2) :35 -9.
  • 7Yoshikawa R, Kusunoki M, Yanagi H, et al. Dual antitumor effects of 5-Fluorouracil on the cell cycle in colorectal carcinoma cells : a novel target mechanism concept for pharmacokinetic modulating chemotherapy [ J ]. Cancer Res,2001,61 ( 3 ) : 1029 - 37.
  • 8Yamane-N, Makino-M, kaibara-N. S-phase accumulation precedes apoptosis induced by preoperative treatment with 5-fluorouracil in human colorectal carcinoma cells [ J ]. Cancer. 1999, Jan 15,85(2) :309 - 17.
  • 9Giatromanolaki A, Stathopoulos G P, Tsiobanou E,et al. Combined role of tumor angiogenesis,bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma [ J ], Cancer, 1999,86(8) :1421 -30.
  • 10Harris GJ,Church JM,Senagore AJ,et al.Factors affecting local recurrence of colonic adenocarcinoma[J].Dis Colon Rectum,2002,45:1029-1034.

共引文献22

同被引文献20

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部